The IRCM Welcomes Major Grant from Quebec Government
The Montreal Clinical Research Institute (IRCM) welcomes the financial contribution of $54,426,939 announced by the Minister of the Economy, Innovation and Energy (MEIE), Mr. Pierre Fitzgibbon, to fund part of the Institute's operating expenses until March 31, 2027.
Thanks to this funding, the IRCM will be able to maintain its research activities in order to accelerate the discovery of cutting-edge diagnostic tools as well as prevention and treatment methods. The funding comes from the Quebec Research and Innovation Investment Strategy 2022 2027.
"We warmly thank the MEIE for this support, which is vital to the pursuit of our mission. This funding will stimulate biomedical innovation through fundamental and clinical discoveries and enable the development of precision therapies for a broad spectrum of diseases that affect people at home and abroad. In the IRCM's laboratories, our scientists are working to lay the foundations for future therapies, and to train scientific leaders who will contribute to the sustainable health of today's and tomorrow's populations." – Dr. Jean François Côté, President and Scientific Director, Montréal Clinical Research Institute
About the IRCM
The IRCM is an independent, leading-edge biomedical research center that brings together researchers and modern technological platforms. 34 laboratories and research clinics work to understand the causes of disease and develop innovative therapies to benefit population health, including the most novel approaches, such as RNA therapeutics. A major player in the training of Quebec's and the world's biomedical research elite, the IRCM also promotes Quebec innovation as part of major international initiatives and collaborations in several promising areas of healthcare.
